Aiolos Bio, Inc. is excited to announce our launch as a clinical-stage biopharmaceutical company dedicated to addressing the unmet needs of patients with respiratory and inflammatory conditions. With an accomplished team brought together by our founder CEO Khurem Farooq and Co-Founder Tony Adamis, an esteemed group of investors supporting our mission, and the potential of our lead drug candidate to be a best-in-class anti-TSLP therapy, we see a unique opportunity to positively impact patients’ asthma outcomes. In addition, we are thrilled to have the leadership of industry veteran @John Milligan who will assume the role of Board Chair at Aiolos Bio. Join us on our exciting journey! #Biopharma #Innovation #RespiratoryHealth #ClinicalTrials https://lnkd.in/gDeBZV5t
Amazing! Good luck on the journey!
Congratulations!!!
Congratulations!
Wow! Congratulations
Senior eClinical Consultant
1yCongratulations, what an amazing accomplishment!